Short-Course Raltegravir Intensification Does Not Increase 2 Long Terminal Repeat Episomal HIV-1 DNA in Patients on Effective Antiretroviral Therapy

Ítems similars

• Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy
  per: McMahon, D., et al.
  Publicat: (2010)
• Frequency of Antiretroviral Resistance Mutations among Infants Exposed to Single-Dose Nevirapine and Short Course Maternal Antiretroviral Regimens: ACTG A5207
  per: Hitti, Jane, et al.
  Publicat: (2014)
• No Effect of Raltegravir Intensification on Viral Replication Markers in the Blood of HIV-1-infected Patients Receiving Antiretroviral Therapy
  per: Gandhi, Rajesh T., et al.
  Publicat: (2012)
• Intensification of antiretroviral treatment with raltegravir for pregnant women living with HIV at high risk of vertical transmission
  per: Puthanakit, Thanyawee, et al.
  Publicat: (2018)
• Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy
  per: Dinoso, J. B., et al.
  Publicat: (2009)